These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 954821)

  • 21. Similar development of tolerance to barbital-induced inhibition of avoidance behavior and loss of righting reflex in rats.
    Richter JA; Harris PS; Hanford PV
    Pharmacol Biochem Behav; 1982 Mar; 16(3):467-71. PubMed ID: 7079283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demonstration of neurochemical tolerance following chronic barbital treatment.
    Lane SJ; Morgan WW
    Neurobehav Toxicol Teratol; 1985; 7(2):195-7. PubMed ID: 2987720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on interactions between striatal dopaminergic and cholinergic mechanisms in the early abstinence after chronic treatment with barbital in the rat.
    Persson SA; Wahlström G
    Subst Alcohol Actions Misuse; 1984; 5(3):149-57. PubMed ID: 6438820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barbital-induced cross-tolerance to barbiturates by the intracisternal route of administration.
    Stolman S; Loh HH
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):309-16. PubMed ID: 1197916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of chronic oral administration of barbital on cerebellar cyclic GMP.
    Lane SJ; Morgan WW
    Neuropharmacology; 1984 Jul; 23(7A):779-83. PubMed ID: 6089024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerance to hexobarbital induced by short-term treatments with diazepam and tested with an EEG-threshold test in male rats.
    Carlsson S; Wahlström G
    Pharmacol Toxicol; 1993 Feb; 72(2):134-8. PubMed ID: 8474966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of tolerance to chronic barbital treatment in the cerebellar cyclic guanosine monophosphate system and its response to subsequent barbital abstinence.
    Lane SJ; Morgan WW
    J Pharmacol Exp Ther; 1985 Sep; 234(3):569-74. PubMed ID: 2993585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between probenecid and two lipid-soluble barbiturates in the rat.
    Bolander HG; Wahlström G
    Neuropharmacology; 1984 Aug; 23(8):977-81. PubMed ID: 6483121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of p-chlorophenylalanine on the acquisition of tolerance to barbital.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Can J Physiol Pharmacol; 1980 Jan; 58(1):12-6. PubMed ID: 6445772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noradrenergic supersensitivity in the rat vas deferens during barbital withdrawal.
    Saban R; De Moraes S
    Eur J Pharmacol; 1977 May; 43(2):195-8. PubMed ID: 559576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of serotonin in tolerance to ethanol and barbiturates: evidence for a specific vs. non-specific concept of tolerance.
    Khanna JM; LeBlanc AE; Le AD
    Drug Alcohol Depend; 1979; 4(3-4):207-19. PubMed ID: 160866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction time measurement of barbital tolerance in mice given recurrent subhypnotic dosage of barbital.
    Risher DL; Baccus AL; Townsend SW; Proctor CD
    J Natl Med Assoc; 1982 Dec; 74(12):1183-7. PubMed ID: 7154102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barbital-induced changes in sensitivity to the behavioral effects of narcotics.
    Carney JM; Rosecrans JA
    Pharmacol Biochem Behav; 1977 May; 6(5):589-90. PubMed ID: 896894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of long-term forced oral barbital administration on endogenous acetylcholine in different regions of rat brain.
    Nordberg A; Wahlström G
    Eur J Pharmacol; 1977 Jun; 43(3):237-42. PubMed ID: 559577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute tolerance to barbiturate in the rat.
    Turnbull MJ; Watkins JW
    Eur J Pharmacol; 1976 Mar; 36(1):15-20. PubMed ID: 944131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drinking and cholinergic mechanisms in the abstinence after chronic barbital treatments.
    Wahlström G
    Scand J Psychol; 1982; Suppl 1():79-84. PubMed ID: 7187992
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of chronic pentobarbital treatment on the development of cross-tolerance to ethanol and barbital.
    Khanna JM; Lê AD; Gougos A; Kalant H
    Pharmacol Biochem Behav; 1988 Sep; 31(1):179-86. PubMed ID: 3252249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in a hexobarbital anaesthesia threshold in rats induced by repeated long-term treatment with barbital or ethanol.
    Wahlström G
    Psychopharmacologia; 1971; 19(4):366-80. PubMed ID: 5105729
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in populations of cholinergic binding sites in brain after chronic exposure to barbital in rats.
    Nordberg A; Wahlström G
    Brain Res; 1982 Aug; 246(1):105-12. PubMed ID: 7127080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased penetration of barbital through the bloodbrain barrier in the rat after pretreatment with probenecid.
    Wahlström G
    Acta Pharmacol Toxicol (Copenh); 1978 Oct; 43(4):260-5. PubMed ID: 716942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.